Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controls
- DOI
- 10.1002/alz.70010
- Published
- 2025-03
- Container
- Alzheimer's & Dementia
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/alz.70010,
title = {Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controls},
author = {Ryan T. Muir and Sophie Stukas and Jennifer G. Cooper and Andrew E. Beaudin and Cheryl R. McCreary and Myrlene Gee and Krista Nelles and Nikita Nukala and Janina Valencia and Kristopher M. Kirmess and Sandra E. Black and Michael D. Hill and Richard Camicioli and Cheryl L. Wellington and Eric E. Smith},
year = {2025},
journal = {Alzheimer's \& Dementia},
doi = {10.1002/alz.70010},
url = {https://doi.org/10.1002/alz.70010}
}RIS
TY - JOUR TI - Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controls AU - Ryan T. Muir AU - Sophie Stukas AU - Jennifer G. Cooper AU - Andrew E. Beaudin AU - Cheryl R. McCreary AU - Myrlene Gee AU - Krista Nelles AU - Nikita Nukala AU - Janina Valencia AU - Kristopher M. Kirmess AU - Sandra E. Black AU - Michael D. Hill AU - Richard Camicioli AU - Cheryl L. Wellington AU - Eric E. Smith PY - 2025 JO - Alzheimer's & Dementia DO - 10.1002/alz.70010 UR - https://doi.org/10.1002/alz.70010 ER -
APA
Muir, R. T., Stukas, S., Cooper, J. G., Beaudin, A. E., McCreary, C. R., Gee, M., Nelles, K., Nukala, N., Valencia, J., Kirmess, K. M., Black, S. E., Hill, M. D., Camicioli, R., Wellington, C. L., & Smith, E. E. (2025). Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controls. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70010
Source records
- crossref · retrieved 2026-09-24T22:48:20.322Z